Pressemitteilungen von Chameleon Pharma Consulting

Chameleon Pharma Consulting ist der Pharma Beratungsexperte für M & A, Sales & Marketing, Vertrieb, Regulatory, R & D in der Region GUS (Russland, Ukraine, Kasachstan, Usbekistan, Weißrussland etc.) und Ost Europa (Polen, Rumänien, Bulgarien etc. ) und verfügt über ein breites Netzwerk mit langjährigen Kontakten. Der Hauptsitz von Chameleon Pharma Consulting liegt in der Nähe des ehemaligen Flughafens Berlin Tempelhof im Herzen der deutschen Hauptstadt. EXPOPHARM 2011: Chameleon Pharma ist mit eigenem Stand vom 06. – 09. Oktober auf der EXPOPHARM 2011 in Düsseldorf vertreten. Besuchen Sie uns auf unserem Chameleon Pharma Stand C10 in Halle 3, „Schloßallee“. Ost Europa, Pharma Business Development, GUS Region, CIS & ...

Letzten 10 Pressemitteilungen

• Polfarma increased its stake in Russian pharma company
  The joint-stock company Polfarma Pharmaceutical Factory increased its stake in OJSC Integrated Chemical and Pharmaceutical Enterprise Akrikin from 72.54% to 98.17%. Akrikhin is the fifth largest local producer by revenue 2010 and one of the fastest growing pharmaceutical companies on the Russian market. The Akrikhin revenue in 2011 grew by almost 18% from 3. 609 billion Rub to 4.254 billion Rub. Chameleon Pharma Consulting comments: During the last year Polfarma has already acquired a big ...
  
  
• ERBD invests in Russian Pharma Company
  Since their establishment in 1991 the ERBD has become the largest financial investor in their region of operations which stretches from central Europe and the Western Balkans to central Asia. With the ability and willingness to bear risk on behalf of their clients, in order to help countries in the region to become open market economies. The ERBD is owned by 63 countries, the European Union and the European Investment Bank. Now the EBRD is going to buy a minority equity stake of around 15 per ...
  
  
• Selling of medicine in Internet is not allowed in Ukraine
  On December 29, 2011 the Ministry of Health (an organ that provides the introduction of state policy in public health) has put a new law concerning internet sales of medicines and drugs in place. From this date the changes for distribution drugs to patients and consumers are the following: • Distance sale of medicine (by post, via Internet or other retail shops with no pharmacy status) are prohibited • Sale of medicine is only allowed in pharmacies • The advertising of prescription drug ...
  
  
• New innovative retail outlets“ supermarket combined with pharmacies” - opened in the suburbs of Moscow
  X5 Retail Group N.V. and “Mosoblformatsiya” announced about signing a joint agreement to establish a network of 60 supermarkets combined with pharmacies in the suburbs of Moscow. The Management believes to sell more units per sqm. compared to traditional pharmacy or supermarket outlets. This in return, will make it possible for the residents of Moscow suburbs to buy essential commodities and medical supplies at discount prices. The first shopping center combined with pharmacy has been opened rec ...
  
  
• Russian Investors attracted by European Healthcare business!
  More and more Russian investors and Pharma companies are interested in West- European healthcare and Pharma / OTC targets. Nowadays the CIS and CEE Pharma markets develop very well, mostly above 15-17%. However the markets are still dominated by more than 80% imported products from West-Europe, Asia and the US. Will this change? What will change? We at Chameleon Pharma Consulting notice that more and more Russian, Ukrainian, Polish and Kazak investors and Pharma cooperations are interested to a ...
  
  
• Polpharma strategic moves to buys a Pharma company in Kazakhstan
  Polpharma has board the controlling share in the Pharma production company Khimpharm in the Shymkent Region in Kazakhstan. ...
  
  
• Chameleon Pharma Consulting with 50 completed projects in the CIS&CEE Region!
  The pharma consulting expert for the health care market in CIS and Eastern Europe - Chameleon Pharma Consulting has competed 50 projects within the last years. The company celebrated this successful record during the participation of the Expopharm 2011. ...
  
  
• Agreement on the mutual recognition procedure of registration certificates for medicines
  made by Member States of the customs union (Russia, Belarus and Kazkhastan) with GMP, plans to introduce in 2012, 2013. ...
  
  
• The EU and Russia agree on mutual recognition of clinical trials
  Health ministry of the Russian Federation has reached an agreement with the European Union (EU) on the issue of mutual recognition of clinical research, said the head of department Golikova. ...
  
  
• Ukraine: No limit for drug and OTC advertising
  The government of Ukraine has refused to limit medical advertisement. For the relevant draft amendments to Article 21 of the law "On Advertising" (under the restriction of drug advertising) N8065 only 69 voted while 226 were needed for a change. ...
  
  
• Compared to 2011 the purchase of drugs in 2012 via the program “7 nostages” will increase by 13%
  The chairman of the Duma Committee of Health, Olga Borzova, announced at the committee meeting on the 7th of October 2011 that: - In 2012 the budget scope of the federal health budget will amount up to 551.1 billion Rubles. - This is nearly 50 billion Rubles more than in the current year (503.7 Billion Rubles) During the meeting, participants also discussed the draft law "On the Federal Budget for 2012 and for the planning period 2013 and 2014". ...
  
  
• In Kazakhstan, the birth rate increased by 25%
  In Kazakhstan, the birth rate increased by 25% in 2010. This was announced by the Minister of Health Salidat Kairbekova in Astana at the International Congress "Innovative Technologies - Progress in Medicine". The congress was also the place where the 10th anniversary of "National Research Medical Centre" was celebrated. ...
  
  
• The leading pharmacy chain “36.6” announced results for the first half of 2011
  and presented their forecast for the retail revenues in 2012 The 36.6 Group does include the leading Russian pharmacy retail chain “36.6” and Veropharm, the company's generics subsidiary, which is one of Russia's top five pharmaceutical manufacturers (according to Pharmexpert research). ...
  
  
• Die deutsche Krueger GmbH wird eine neue Vitamin Fabrik für $ 25 Mio. in Usbekistan bauen.
  Übereinstimmenden Berichten zufolge wird der deutsche FMCG und Pharma Riese Krueger GmbH & Co KG eine Vitamin Fabrik für $ 25 Mio. in Usbekistan bauen. ...
  
  
• Die strategische Perspektiven für den Pharma Mittelstand mit Russlands Pharma Programm 2020
  Russland schafft Gesetze und Pläne für die Entwicklung der lokalen pharmazeutischen Industrie. ...
  
  
• Belarus ruft das „BelBiograd“ ins Leben
  Weißrussland plant in der Zukunft die Aufbau eigenen multifunktionalen Wissenschafts- und Technologieparks in Bereichen der Pharma-, Bio- und Nanotechnologie. ...
  
  
• Chameleon Pharma Consulting übernimmt RC- Pharma Consulting
  Der Pharma Beratungsexperte für den Healthcare Markt in GUS und Ost-Europa - Chameleon Pharma Consulting übernimmt RC-Pharma Consulting und wächst mit erweitertem Management auf über 50 Jahre Berufserfahrung in der Region GUS und Osteuropa. ...
  
  
• Pharmacy chain A.S. Watson mit neuer Ausrichtung in der Ukraine
  A.S. Watson hat die kontrollierende Mehrheit der „DC“ Apothekenkette übernommen und alle Outlets gemäß des Watsons Designs neugebrandet: ...